angiodynamics.com (ANGO): Rentabilitas operasi

AngioDynamics Corp (ANGO) - logo korporat

AngioDynamics, Inc. (ANGO) is pivoting away from low-cost consumables to avoid pricing pressure. This margin-expansion strategy is linked to the implementation of NanoKnife AI systems for cancer treatment. Manufacturing capacities in the UK and US ensure the uninterrupted production of instruments. The operating profitability history clearly demonstrates profit dynamics, and -6.00 reflects the latest value of the metric.

ANGO - Rasio bathi operasi AngioDynamics ing rentang 04.07.2022 - 19.11.2026

Rincian analitis lan laporan data perusahaan angiodynamics.com (ANGO)

- rega saham lan konsensus proyeksi valuasi:
Analisis umum perusahaan:AngioDynamics Inc, ANGO
Produk dadi AngioDynamics, Inc.

The operating margin of AngioDynamics, Inc. (ANGO) reflects the production efficiency of medical systems before accounting for financial expenses and taxes. This metric measures the share of profit from core operations relative to total sales, which is critical for assessing profitability. The current operating income as a percentage of revenue stands at -6.00. The trend of this indicator reveals the business's vulnerability to supply chain disruptions and sanction-related restrictions in target markets. Margin stability confirms the company's fundamental resilience to geopolitical shocks.

Pesaing AngioDynamics, Inc. (ANGO)

ISRG (intuitive.com) - Margin operasi|Rentabilitas dodolan miturut bathi operasi DHR (Danaher Corp.)|Margin dodolan operasi BDX (Becton, Dickinson and Company)|Rasio bathi operasi STE|Rentabilitas operasi West Pharma WST|Rentabilitas kegiatan operasi Baxter (BAX)|MASI - Rentabilitas operasi|Rentabilitas kegiatan operasi Stevanato Group Corp STVN|TFX: Margin operasi|Margin dodolan operasi Merit Medical Systems|Rentabilitas operasi Envista Holdings Corp|Margin dodolan operasi ICU Medical Corp (ICUI)|Rentabilitas operasi DENTSPLY SIRONA Inc. (XRAY)|Margin dodolan operasi LeMaitre LMAT|Margin operasi ATRC (atricure.com)|Margin operasi staar.com STAA|NAGE - Rentabilitas operasi|Rentabilitas kegiatan operasi ZimVie ZIMV|CERS (Cerus Corp) - Margin dodolan operasi|Alpha Teknova, Inc. - Tingkat bathi operasi|MGRM (Monogram Orthopedics Inc.) - Margin operasi|STSS: Tingkat bathi operasi|Margin dodolan operasi INFU (InfuSystem Holdings)|Utah Medical Products, Inc. - Rentabilitas dodolan miturut bathi operasi|Margin operasi KRMD (korumedical.com)|Rentabilitas kegiatan operasi Nyxoah, S.A. (NYXH)|MBOT - Rentabilitas operasi|PDEX (Pro-Dex, Inc.) - Rentabilitas dodolan miturut bathi operasi|ZTEK (Zentek Ltd) - Margin dodolan operasi|ELUT - Rentabilitas kegiatan operasi|MLSS (Milestone Scientific Corporation) - Margin operasi|Rentabilitas dodolan miturut bathi operasi NXGL (NEXGEL, Inc.)|Margin operasi RVP|Margin dodolan operasi Harvard Bioscience HBIO|Margin operasi FEMY (Femasys Corporation)|MHUA - Margin dodolan operasi|POAI - Rentabilitas operasi|Callan JMB (CJMB) - Margin dodolan operasi|ATRI: Margin operasi|NURO - Rentabilitas kegiatan operasi